Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis

• Y. López,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Institute of Global Health of Barcelona, Barcelona, Spain

  ⨯
• M. Tato,

  Roles Investigation, Methodology

  Affiliation Department of Clinical Microbiology, Hospital Universitario Ramón y Cajal & Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain

  ⨯
• D. Gargallo-Viola,

  Roles Conceptualization, Supervision, Validation

  Affiliation ABAC Therapeutics, Barcelona, Spain

  ⨯
• R. Cantón,

  Roles Conceptualization, Formal analysis

  Affiliation Department of Clinical Microbiology, Hospital Universitario Ramón y Cajal & Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain

  ⨯
• J. Vila ,

  Roles Conceptualization, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: jvila@ub.edu

  Affiliations Institute of Global Health of Barcelona, Barcelona, Spain, Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Spain

  ⨯
• I. Zsolt

  Roles Conceptualization, Formal analysis

  Affiliation Medical Department, Ferrer Internacional, Barcelona, Spain

  http://orcid.org/0000-0002-8900-722X

  ⨯